Investigation of the Relationship between Electronic Structures and Bioactivities of Polypyridyl Ru(II) Complexes
Open Access
Abstract
Ruthenium (Ru)-based organometallic drugs have gained attention as chemotherapeutic and bioimaging agents due to their fewer side effects and excellent physical optical properties. Tuning the electronic structures of Ru complexes has been proven to increase the cytotoxicity of cancer cells and the luminescent efficiency of the analytical probes. However, the relationship between electronic structures and bioactivities is still unclear due to the potential enhancement of both electron donor and acceptor properties. Thus, we investigated the relationship between the electronic structures of Ru(II) complexes and cytotoxicity by optimizing the electron-withdrawing (complex 1), electron-neutral (complex 2), and electron-donating (complex 3) ligands through DFT calculations, bioactivities tests, and docking studies. Our results indicated that it was not sufficient to consider only either the effect of electron-withdrawing or electron-donating effects on biological activities instead of the total electronic effects. Furthermore, these complexes with electron-donating substituents (complex 3) featured unique “off-on” luminescent emission phenomena caused by the various “HOMO-LUMO” distributions when they interacted with DNA, while complex with electron-withdrawing substituent showed an “always-on” signature. These findings offer valuable insight into the development of bifunctional chemotherapeutic agents along with bioimaging ability.Keywords
Funding Information
- National Natural Science Foundation of China Project (81901811, 215-432000282, 215-432094250, 2021J104, 2022S128, IFKSUOR3-527-1)
- Scientific Research Grant of Ningbo University (81901811, 215-432000282, 215-432094250, 2021J104, 2022S128, IFKSUOR3-527-1)
- Ningbo Top Talent Project (81901811, 215-432000282, 215-432094250, 2021J104, 2022S128, IFKSUOR3-527-1)
- Natural Science Foundation of Ningbo Municipality (81901811, 215-432000282, 215-432094250, 2021J104, 2022S128, IFKSUOR3-527-1)
- Science and Technology Plan Project of Ningbo City (81901811, 215-432000282, 215-432094250, 2021J104, 2022S128, IFKSUOR3-527-1)
- Deputyship for Research & Innovation, “Ministry of Education” in Saudi Arabia (81901811, 215-432000282, 215-432094250, 2021J104, 2022S128, IFKSUOR3-527-1)
This publication has 42 references indexed in Scilit:
- A ruthenium(II) anthraquinone complex as the theranostic agent combining hypoxia imaging and HIF-1α inhibitionInorganica Chimica Acta, 2017
- DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexesDalton Transactions, 2016
- Targeting Nucleus DNA with a Cyclometalated Dipyridophenazineruthenium(II) ComplexJournal of Medicinal Chemistry, 2014
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical applicationChemical Science, 2014
- Further Observations on Water Oxidation Catalyzed by Mononuclear Ru(II) ComplexesInorganic Chemistry, 2012
- Diastereospecific and Diastereoselective Syntheses of Ruthenium(II) Complexes Using N,N‘ Bidentate Ligands Aryl-pyridin-2-ylmethyl-amine ArNH-CH2-2-C5H4N and Their Oxidation to Imine LigandsInorganic Chemistry, 2006
- DNA dynamics: a fluorescence resonance energy transfer study using a long-lifetime metal-ligand complexArchives of Pharmacal Research, 2002
- DNA Damage and Cell Killing by Camptothecin and Its Derivative in Human Leukemia HL‐60 CellsJapanese Journal of Cancer Research, 1993
- STRUCTURE-ACTIVITY STUDY OF THE ACTIONS OF CAMPTOTHECIN DERIVATIVES ON MAMMALIAN TOPOISOMERASE-I - EVIDENCE FOR A SPECIFIC RECEPTOR-SITE AND A RELATION TO ANTITUMOR-ACTIVITY1989
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969